Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain - PubMed (original) (raw)
. 2008 Apr 25;283(17):11340-7.
doi: 10.1074/jbc.M708740200. Epub 2008 Feb 20.
Affiliations
- PMID: 18287102
- DOI: 10.1074/jbc.M708740200
Free article
Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain
Steffen Runge et al. J Biol Chem. 2008.
Free article
Abstract
The glucagon-like peptide-1 receptor (GLP-1R) belongs to Family B1 of the seven-transmembrane G protein-coupled receptors, and its natural agonist ligand is the peptide hormone glucagon-like peptide-1 (GLP-1). GLP-1 is involved in glucose homeostasis, and activation of GLP-1R in the plasma membrane of pancreatic beta-cells potentiates glucose-dependent insulin secretion. The N-terminal extracellular domain (nGLP-1R) is an important ligand binding domain that binds GLP-1 and the homologous peptide Exendin-4 with differential affinity. Exendin-4 has a C-terminal extension of nine amino acid residues known as the "Trp cage", which is absent in GLP-1. The Trp cage was believed to interact with nGLP-1R and thereby explain the superior affinity of Exendin-4. However, the molecular details that govern ligand binding and specificity of nGLP-1R remain undefined. Here we report the crystal structure of human nGLP-1R in complex with the antagonist Exendin-4(9-39) solved by the multiwavelength anomalous dispersion method to 2.2A resolution. The structure reveals that Exendin-4(9-39) is an amphipathic alpha-helix forming both hydrophobic and hydrophilic interactions with nGLP-1R. The Trp cage of Exendin-4 is not involved in binding to nGLP-1R. The hydrophobic binding site of nGLP-1R is defined by discontinuous segments including primarily a well defined alpha-helix in the N terminus of nGLP-1R and a loop between two antiparallel beta-strands. The structure provides for the first time detailed molecular insight into ligand binding of the human GLP-1 receptor, an established target for treatment of type 2 diabetes.
Similar articles
- Differential structural properties of GLP-1 and exendin-4 determine their relative affinity for the GLP-1 receptor N-terminal extracellular domain.
Runge S, Schimmer S, Oschmann J, Schiødt CB, Knudsen SM, Jeppesen CB, Madsen K, Lau J, Thøgersen H, Rudolph R. Runge S, et al. Biochemistry. 2007 May 15;46(19):5830-40. doi: 10.1021/bi062309m. Epub 2007 Apr 20. Biochemistry. 2007. PMID: 17444618 - Glucagon-like peptide-1 receptor ligand interactions: structural cross talk between ligands and the extracellular domain.
West GM, Willard FS, Sloop KW, Showalter AD, Pascal BD, Griffin PR. West GM, et al. PLoS One. 2014 Sep 2;9(9):e105683. doi: 10.1371/journal.pone.0105683. eCollection 2014. PLoS One. 2014. PMID: 25180755 Free PMC article. - Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor.
Coopman K, Wallis R, Robb G, Brown AJ, Wilkinson GF, Timms D, Willars GB. Coopman K, et al. Mol Endocrinol. 2011 Oct;25(10):1804-18. doi: 10.1210/me.2011-1160. Epub 2011 Aug 25. Mol Endocrinol. 2011. PMID: 21868452 Free PMC article. - 18F-Labeled exendin(9-39).
Chopra A. Chopra A. 2012 Feb 9 [updated 2012 May 17]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2012 Feb 9 [updated 2012 May 17]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 22624171 Free Books & Documents. Review. - Exendin-4 from Heloderma suspectum venom: From discovery to its latest application as type II diabetes combatant.
Yap MKK, Misuan N. Yap MKK, et al. Basic Clin Pharmacol Toxicol. 2019 May;124(5):513-527. doi: 10.1111/bcpt.13169. Epub 2018 Dec 12. Basic Clin Pharmacol Toxicol. 2019. PMID: 30417596 Review.
Cited by
- Imaging NF-κB activity in a murine model of early stage diabetes.
Taghian T, Metelev VG, Zhang S, Bogdanov AA Jr. Taghian T, et al. FASEB J. 2020 Jan;34(1):1198-1210. doi: 10.1096/fj.201801147R. Epub 2019 Nov 29. FASEB J. 2020. PMID: 31914655 Free PMC article. - Membrane-tethered ligands are effective probes for exploring class B1 G protein-coupled receptor function.
Fortin JP, Zhu Y, Choi C, Beinborn M, Nitabach MN, Kopin AS. Fortin JP, et al. Proc Natl Acad Sci U S A. 2009 May 12;106(19):8049-54. doi: 10.1073/pnas.0900149106. Epub 2009 Apr 23. Proc Natl Acad Sci U S A. 2009. PMID: 19416829 Free PMC article. - The Influence of Peptide Context on Signaling and Trafficking of Glucagon-like Peptide-1 Receptor Biased Agonists.
Fang Z, Chen S, Pickford P, Broichhagen J, Hodson DJ, Corrêa IR Jr, Kumar S, Görlitz F, Dunsby C, French PMW, Rutter GA, Tan T, Bloom SR, Tomas A, Jones B. Fang Z, et al. ACS Pharmacol Transl Sci. 2020 Mar 17;3(2):345-360. doi: 10.1021/acsptsci.0c00022. eCollection 2020 Apr 10. ACS Pharmacol Transl Sci. 2020. PMID: 32296773 Free PMC article. - Over-expression, purification and isotopic labeling of a tag-less human glucose-dependent insulinotropic polypeptide (hGIP).
Chandarana RC, Vikrant, Varma AK, Saran A, Coutinho EC, D'Souza JS. Chandarana RC, et al. 3 Biotech. 2014 Oct;4(5):501-506. doi: 10.1007/s13205-013-0181-x. Epub 2013 Oct 31. 3 Biotech. 2014. PMID: 28324382 Free PMC article. - Structure-activity relationships for α-calcitonin gene-related peptide.
Watkins HA, Rathbone DL, Barwell J, Hay DL, Poyner DR. Watkins HA, et al. Br J Pharmacol. 2013 Dec;170(7):1308-22. doi: 10.1111/bph.12072. Br J Pharmacol. 2013. PMID: 23186257 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases